Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 5/20 | 0.68 |
| ▸ | CA12 | O43570 | 2/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 2/20 | 0.60 |
| ▸ | CA4 | P22748 | 2/20 | 0.60 |
| ▸ | CA6 | P23280 | 2/20 | 0.60 |
| ▸ | CA7 | P43166 | 2/20 | 0.60 |
| ▸ | CA9 | Q16790 | 2/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.60 |
| ▸ | CA3 | P07451 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | CA5A | P35218 | 1/20 | 0.60 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | CNR2 | P34972 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL312132 | 0.88 | TPMT (0.55) | TPMTCA12CA1CA2CA4 | |
| 3,4,5-Trimethoxybenzoic Acid SCHEMBL6592 | 0.88 | TPMT (0.78) | TPMTCA12CA1CA2CA4 | |
| 3,4,5-Trimethoxybenzoic Acid SCHEMBL4080846 | 0.86 | TPMT (0.75) | TPMTCA12CA1CA2CA4 | |
| 3,4,5-Trimethoxybenzoic Acid SCHEMBL9739818 | 0.86 | TPMT (0.75) | TPMTCA12CA1CA2CA4 | |
| 3,4,5-Trimethoxybenzoic Acid SCHEMBL10838612 | 0.86 | TPMT (0.75) | TPMTCA12CA1CA2CA4 | |
| 3,4,5-Trimethoxybenzoic Acid SCHEMBL11023602 | 0.86 | TPMT (0.75) | TPMTCA12CA1CA2CA4 | |
| Hydrochloric Acid SCHEMBL11851061 | 0.86 | TPMT (0.53) | TPMTCA12CA1CA2CA4 | |
| SCHEMBL786462 | 0.85 | LMNA (0.60) | TPMTKMT2AHTTPOLBMEN1 | |
| SCHEMBL11893913 | 0.84 | TPMT (0.54) | TPMTCA12CA1CA2CA4 | |
| 3,4,5-Trimethoxybenzoic Acid SCHEMBL9427206 | 0.84 | TPMT (0.72) | TPMTCA12CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108003032-A | It is a kind of（1,1- bis-fluoro ethyls）Diphenyl ethylene derivatives and its preparation method and application | 上海应用技术大学 | 2018-05-08 | — | — | CN | claimed |
| CN-103301102-A | Method for extracting antioxidant from myricaria laxiflora and application thereof | UNIV CHINA THREE GORGES CTGU | 2013-09-18 | — | — | CN | claimed |
| EP-2970595-B1 | HIGH PURITY LIGNIN, LIGNIN COMPOSITIONS, AND HIGHER STRUCTURED LIGNIN | RENMATIX INC (US) | 2018-07-11 | — | — | EP | disclosed |
| CN-108003032-A | It is a kind of（1,1- bis-fluoro ethyls）Diphenyl ethylene derivatives and its preparation method and application | 上海应用技术大学 | 2018-05-08 | — | — | CN | disclosed |
| CN-107582702-A | Medicine Wax composition for traditional Chinese medical science wax therapy and preparation method thereof | 桂阳神农蜂生态农业有限公司 | 2018-01-16 | — | — | CN | disclosed |
| US-9512362-B2 | Compound, liquid crystal composition, polymer material and film | FUJIFILM CORPORATION (JP) | 2016-12-06 | — | — | US | disclosed |
| CN-103301102-B | Method for extracting antioxidant from myricaria laxiflora and application thereof | UNIV CHINA THREE GORGES CTGU | 2015-01-07 | — | — | CN | disclosed |
| US-20140374657-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, POLYMER MATERIAL AND FILM | FUJIFILM CORPORATION (JP) | 2014-12-25 | — | — | US | disclosed |
| CN-103301102-A | Method for extracting antioxidant from myricaria laxiflora and application thereof | UNIV CHINA THREE GORGES CTGU | 2013-09-18 | — | — | CN | disclosed |
| US-20110287059-A1 | HONEY ANALYSIS | COMVITA NEW ZEALAND LIMITED (NZ) | 2011-11-24 | — | — | US | disclosed |
| US-7696195-B2 | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-04-13 | — | — | US | disclosed |
| EP-1645556-A1 | Arylpiperazine-benzoylamide derivatives useful as pharmaceutical agents | Boehringer Ingelheim International GmbH (DE) | 2006-04-12 | — | — | EP | disclosed |
| US-20050256099-A1 | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110287059-A1 | HONEY ANALYSIS | GLO1, GLMN, AGER | TPMT 1929/4885CA12 811/4885CA1 1225/4885 |
| US-20050256099-A1 | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | CALCRL, CALCR, CALCA | TPMT 2504/4885CA12 3064/4885CA1 1869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.